Format

Send to

Choose Destination
Pediatr Infect Dis J. 2010 Dec;29(12):1133-5. doi: 10.1097/INF.0b013e3181ed18ab.

Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital.

Author information

1
Center for Vaccine Awareness and Research, Texas Children's Hospital, Houston, TX 77030, USA. jboom@bcm.edu

Abstract

Fecal specimens from children presenting to Texas Children's Hospital with acute gastroenteritis were tested for the presence of rotavirus. Children were grouped according to vaccination status, and pentavalent rotavirus vaccine effectiveness was calculated. Pentavalent rotavirus vaccine effectiveness against severe rotavirus gastroenteritis was sustained during the first 2 years of the vaccination program. Overall 3-dose effectiveness was 83% to 86%; it was 92% to 93% among children 6 to 11 months of age and 78% to 84% among children ≥12 months of age.

PMID:
20634776
DOI:
10.1097/INF.0b013e3181ed18ab
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center